Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Hoth Therapeutics seeks IPO cash to battle eczema
Hoth Therapeutics seeks IPO cash to battle eczema
Hoth Therapeutics seeks IPO cash to battle eczema
Submitted by
admin
on October 12, 2018 - 10:21am
Source:
Fierce Biotech
News Tags:
Hoth Therapeutics
IPOs
NASDAQ
eczema
Headline:
Hoth Therapeutics seeks IPO cash to battle eczema
snippet:
Hoth Therapeutics has filed to raise around $11 million in a Nasdaq IPO. The tiny offering will equip Hoth to test a topical formulation of the broad-spectrum antibiotic gentamicin in a phase 2 eczema trial.
Do Not Allow Advertisers to Use My Personal information
